Overall, our results show that tumors with strong CD8+ T-cell infiltration, or high mutation burden, or exogenous viral infection, or endogenous retroviral expression have high IDO-1 expression in most cancer types, high IDO-2 expression in many cancer types, but high TDO-2 expression in only a few cancer types. This evidence concerns the gene IDO2 and viral infectious disease.